Ahmad Alsahli | Dentistry | Best Researcher Award

Posted on by Research Data Analysis

Dr. Ahmad Alsahli | Dentistry | Best Researcher Award

Kuwait University | Kuwait

Publication Profile

Orcid

đŸ’Œ Current Position

Dr. Ahmad Alsahli is an Assistant Professor at the Faculty of Dentistry, Kuwait University, where he serves full-time in the Department of General Dental Practice. In addition to his academic responsibilities, he actively practices clinical dentistry as an Associate Dentist at Bayan Dental – Alhamra Branch in Kuwait, maintaining a balanced role in both education and private healthcare.

📘 Education & Experience

Dr. Alsahli holds a Doctor of Dental Surgery (DDS) degree from Virginia Commonwealth University (VCU), earned in 2007. He further advanced his expertise with an Advanced Education in General Dentistry (AEGD) from Columbia University College of Dental Medicine, followed by a Master of Arts in Dental Sciences from Columbia University’s Graduate School of Arts and Sciences in 2014. His clinical experience spans both the U.S. and Kuwait, including roles in private practice, public health clinics, and faculty-based clinical settings. Since 2014, he has been practicing and teaching in Kuwait, providing hands-on education in restorative dentistry and patient care.

✅ Suitability Summary

With over 15 years of diverse clinical and academic experience, Dr. Alsahli brings a deep understanding of general dentistry, restorative procedures, and patient-focused care. His dual roles as an educator and practitioner allow him to integrate current clinical knowledge into his teaching, providing students with real-world insight. His board certification, academic fellowships, and international clinical exposure make him particularly suited for leadership roles in dental education and general dentistry.

🎓 Professional Development

Dr. Alsahli is a Diplomate of the American Board of General Dentistry (ABGD) and a Fellow of the Academy of General Dentistry (FAGD), credentials that underscore his commitment to continuous learning and clinical excellence. He has passed the National Dental Board Examination Parts I & II and the SRTA clinical board exam. His involvement in professional organizations like the Academy of General Dentistry and the International Association of Dental Research reflects his dedication to both professional growth and scientific advancement in the dental field.

🔬 Research Focus

While primarily a clinician and educator, Dr. Alsahli’s academic background in dental sciences supports his involvement in educational and clinical research. His research interests align with general dentistry practices, restorative techniques, and the enhancement of clinical education methods. His academic role allows him to contribute to the development of evidence-based teaching approaches and to mentor students in research initiatives.

🏆 Honors & Awards

Dr. Alsahli’s professional milestones include becoming a Diplomate of the ABGD in 2014 and earning the title of Fellow of the Academy of General Dentistry in 2017—both of which are considered prestigious honors within the dental profession. Additionally, his active service in community dental missions such as Missions of Mercy in Virginia and the Jamaica Project reflects a strong commitment to humanitarian outreach and public oral health.

📚 Top Notes Publications

Title: Palmitic acid reduces circulating bone formation markers in obese animals and impairs osteoblast activity via C16-ceramide accumulation

    • Authors: Ahmad Alsahli, Kathryn Kiefhaber, Tziporah Gold, Munira Muluke, Hongfeng Jiang, Serge Cremers, Ulrike Schulze-SpĂ€te

    • Journal: Calcified Tissue International

    • Year: 2016

Title: Diet-induced obesity and its differential impact on periodontal bone loss

    • Authors: Munira Muluke, Tziporah Gold, Kathryn Kiefhaber, Ahmad Al-Sahli, Rebecca Celenti, Hongfeng Jiang, Serge Cremers, Thomas Van Dyke, Ulrike Schulze-SpĂ€te

    • Journal: Journal of Dental Research (J Dent Res)

    • Year: 2016

Title: Oral Health in the State of Kuwait: An Appraisal

    • Authors: H. Nazar, S. Al-Mutawa, AAR Asad, J. Ariga, A. AlSahli, JK Baskaradoss

    • Journal: International Dental Journal (Int Dent J)

    • Year: 2024

Isabel Lastres-Becker | Emerging Research Trends | Best Researcher Award

Posted on by Research Data Analysis

Dr. Isabel Lastres-Becker | Emerging Research Trends | Best Researcher Award

Universidad AutĂłnoma de Madrid | Spain

PUBLICATION PROFILE

Scopus

Orcid

INTRODUCTION đŸ‘©â€đŸ”Ź

Dr. Isabel Lastres-Becker is an Associate Professor at the Universidad AutĂłnoma de Madrid, specializing in biochemistry and neurodegenerative diseases. With over 20 years of research experience, her scientific work primarily focuses on the molecular mechanisms of neurodegeneration, including oxidative stress, neuroinflammation, and proteinopathies. Her contributions span several neurodegenerative disorders, including Parkinson’s disease, Alzheimer’s, ALS, and Huntington’s disease.

EARLY ACADEMIC PURSUITS 🎓

Dr. Lastres-Becker completed her Licenciatura en Ciencias Químicas (Bachelor’s degree in Chemistry) with a specialization in Biochemistry from Universidad Complutense de Madrid in 1997. She later earned her PhD in Biochemistry in 2003 from the same institution, with a focus on neurodegenerative diseases. Her doctoral research was awarded the prestigious European mention.

PROFESSIONAL ENDEAVORS đŸ‘©â€đŸ«

Throughout her career, Dr. Lastres-Becker has held various academic and research positions. She is currently an Associate Professor at the Universidad AutĂłnoma de Madrid since October 2021, after having previously served as a RamĂłn y Cajal researcher and Postdoctoral Researcher in Spain and Germany. Her experience in both the academic and research environments has greatly contributed to her expertise in neurodegenerative diseases.

CONTRIBUTIONS AND RESEARCH FOCUS 🔬

Dr. Lastres-Becker’s research contributions have had a significant impact on the understanding of neurodegenerative diseases. Her work has focused on various aspects:

  • Cannabinoid System in Huntington’s Disease: Dr. Lastres-Becker explored how the dysregulation of the endogenous cannabinoid system affects Huntington’s disease. Her work laid the groundwork for clinical trials examining the neuroprotective effects of cannabinoids.
  • Parkinson’s Disease: She demonstrated how cannabinoid receptors, particularly CB1, are involved in neuroinflammation in Parkinson’s disease, and her research suggested potential therapeutic targets for modulating microglial activity.
  • Ataxin-2 in Spinocerebellar Ataxia: She was the first to identify the role of ataxin-2 in metabolism and protein synthesis, as well as its involvement in SCA2 neurodegeneration.
  • NRF2 Transcription Factor: Dr. Lastres-Becker’s research on NRF2 has revealed its central role in neurodegenerative diseases. She showed how NRF2’s involvement in inflammatory processes could be a therapeutic target, particularly in the context of Parkinson’s disease and tauopathies.
  • Neuron-Glia Communication: In Alzheimer’s disease, Dr. Lastres-Becker identified how neurons with overexpressed TAU protein release fractalkine (CX3CL1), triggering neuroinflammation and tau-related neurodegeneration.

IMPACT AND INFLUENCE 🌍

Dr. Lastres-Becker’s research is not only impactful within the academic sphere but also in the broader scientific and clinical communities. She serves as an external collaborator with several research groups and is a reviewer for high-impact scientific journals. Additionally, her collaborations with international research agencies and companies have advanced the therapeutic exploration of neurodegenerative diseases.

ACADEMIC CITATIONS AND PUBLICATIONS 📚

Dr. Lastres-Becker has authored more than 65 publications, contributing significantly to neurodegenerative disease research. Some of her high-impact publications include studies on the cannabinoid system, NRF2 modulation, and tauopathies, with her work frequently cited in the fields of neurobiology and pharmacology. These studies have not only contributed to scientific knowledge but have also provided the foundation for potential clinical therapies.

HONORS & AWARDS 🏆

Throughout her career, Dr. Lastres-Becker has received numerous awards and grants, including funding from the Spanish Ministry of Science and Innovation. Her work has been recognized through various prestigious research projects aimed at studying and developing therapeutics for Parkinson’s disease, ALS, and Alzheimer’s disease.

LEGACY AND FUTURE CONTRIBUTIONS 🔼

Looking ahead, Dr. Lastres-Becker continues to contribute to the advancement of therapeutic strategies for neurodegenerative diseases. She is currently involved in various cutting-edge research projects focused on the roles of NRF2, cannabinoids, and proteostasis. Her future work aims to bridge the gap between preclinical discoveries and clinical applications, ultimately improving treatment outcomes for patients with these devastating conditions.

TOP NOTES PUBLICATIONS 📚

Model organisms for investigating the functional involvement of NRF2 in non-communicable diseases
    • Authors: A.I. Rojo, B. Buttari, S. Cadenas, I.P. Trougakos, A.T. Dinkova-Kostova
    • Journal: Redox Biology
    • Year: 2025
Investigation in the cannabigerol derivative VCE-003.2 as a disease-modifying agent in a mouse model of experimental synucleinopathy
    • Authors: S. Burgaz, E. Navarro, S. RodrĂ­guez-Carreiro, E.E. Muñóz, J.J. FernĂĄndez-Ruiz
    • Journal: Behavioral and Brain Functions
    • Year: 2024
Beneficial Effect of Dimethyl Fumarate Drug Repositioning in a Mouse Model of TDP-43-Dependent Frontotemporal Dementia
    • Authors: I. Silva-Llanes, R. MartĂ­n-Baquero, A. Berrojo-Armisen, E. De Lago, I. Lastres-Becker
    • Journal: Antioxidants
    • Year: 2024
Biomarkers of NRF2 signalling: Current status and future challenges
    • Authors: C. Morgenstern, I. Lastres-Becker, B.C. Demirdogen, A. Cuadrado, I.M. Copple
    • Journal: Redox Biology
    • Year: 2024
RIPK1 expression and inhibition in tauopathies: implications for neuroinflammation and neuroprotection
    • Authors: I. Silva-Llanes, E. Madruga, A.R. MartĂ­nez, I. Lastres-Becker
    • Journal: Frontiers in Neuroscience
    • Year: 2024